Magazine Article | December 1, 2022

The Rise Of Computational Biology In Biopharma

Source: Life Science Leader

By Matthew Pillar, Editor, Bioprocess Online

Life Science Leader Editorial Director Dan Schell’s request of me to write about “the” trend in biopharma was a pretty tall order. There’s a lot going on right now. I could go long on the turbulent biopharma economy and its impact on the innovation coming out of emerging biotech companies. I could rehash the broken supply chain and why its prognosis is not promising. I could write about RNA-anything and likely generate clicks. I could dig into the (still) nascent promise (and peril) of cell and gene therapies. But all that stuff is thoroughly covered regularly around here. It’s all important, but I thought I’d peel a layer off the onion to reveal a trend that’s gaining momentum and having a positive impact during a somewhat negative biopharma news cycle: computational biology.

access the Magazine Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.

Subscribe to Life Science Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Life Science Leader